The Dow rose 0.20 percent to 34,571.92 in mid-day trading on Thursday, while the NASDAQ dipped 0.24 percent to 14,468.72. The S&P 500 gained 0.24 percent to 4,307.60.
The United States has the largest number of coronavirus cases and deaths in the world, with 33,664,890 cases and 604,710 deaths reported. In India, there were at least 30,411,630 cases confirmed, with 399,470 deaths, whereas in Brazil, there were over 18,557,140 COVID-19 cases verified, with 518,060 deaths. According to data provided by Johns Hopkins University, there were at least 182,981,830 cases of COVID-19 worldwide, with more than 3,962,870 deaths.
Sectors that are leading and those that are lagging
On Thursday, energy stocks gained 1.5 percent. Meanwhile, the sector’s top gainers were U.S. Silica Holdings, Inc. (NYSE: SLCA) and Earthstone Energy, Inc. (NYSE: ESTE), both up 11 percent.
Information technology stocks declined 0.3 percent in Thursday’s trading.
Headline 1:
The third quarter results of Walgreens Boots Alliance Inc (NASDAQ: WBA) were better than projected.
Walgreens reported $1.38 earnings per share in the third quarter, topping the consensus expectation of $1.17. Revenue climbed 12.1 percent year over year to $34.0 billion, slightly ahead of the $33.76 billion average estimate.
WBA boosted its constant currency-adjusted EPS from continuing operations guidance for FY21 from mid-to-high single digits to roughly 10%.
Equities are rising in value.
The stock of Pop Culture Group Co., Ltd. (NASDAQ: CPOP) jumped 94 percent to $58.80. Pop Culture Group’s stock soared 405 percent on Wednesday after the business announced its initial public offering (IPO) at $6 per share.
TRxADE HEALTH, Inc. (NASDAQ: MEDS) stock jumped 61 percent to $7.09 after the company’s Bonum Health subsidiary announced a telemedicine service distribution agreement with Big Y Pharmacy.
Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) saw its stock rise 19 percent to $17.94 after the business priced 10.1 million shares in a follow-on secondary public offering at $15.03 per share.
Take a look at today’s big movers.
Trading in equities is down.
Despite receiving a favourable recommendation from the Independent Data Monitoring Committee to continue the Mino-Lok Phase 2 trial as planned, Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) shares fell 20% to $2.7750.
After the business revealed final findings from its Phase 2 pilot HEPANOVA study in liver cancer, shares of NovoCure Limited (NASDAQ: NVCR) fell 16 percent to $187.12.
Aligos Therapeutics, Inc. (NASDAQ: ALGS) lost 16 percent of its value to $17.10. Aligos Therapeutics priced a previously announced underwritten public offering of 4.4 million shares at $19 per share, a 7 percent discount from the previous day’s close of $20.3.
Commodities
Oil rose 2.3 percent to $75.15 in commodity news, while gold rose 0.2 percent to $1,774.80.
Silver rose 0.1 percent to $26.195 on Thursday, while copper dipped 0.1 percent to $4.2845.
The Eurozone
Today, European stocks were up. The STOXX 600 index in the eurozone increased by 0.62 percent, while the Spanish Ibex Index increased by 1.26 percent and the German DAX 30 increased by 0.48 percent. Meanwhile, the FTSE 100 in London increased by 1.1 percent, the CAC 40 in France increased by 0.77 percent, and the FTSE MIB in Italy increased by 0.66 percent.
The manufacturing PMI in Italy fell to 62.2 in June from 62.3 the previous month, while the manufacturing PMI in Spain fell to 60.4 from 59.4. In May, retail sales in Germany increased by 4.2 percent.
Economics
In June, employers in the United States reported a total of 20,476 job layoffs.
In the week ending June 26th, new unemployment claims in the United States fell to 364,000.
In June, the IHS Markit manufacturing PMI was 62.1.
In June, the ISM manufacturing PMI fell to 60.6 from 61.2 in May.
In May, construction spending declined 0.3 percent to $1.545 trillion on an annual basis.
Raphael Bostic, President of the Federal Reserve Bank of Atlanta, will talk at 2:00 p.m. ET.
The complete economic calendar can be seen here (C) 2021. Benzinga.com. Benzinga does not offer financial advice. All intellectual property rights are reserved./n
